BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38577075)

  • 1. Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease.
    Gu P; Dube S; Gellada N; Choi SY; Win S; Lee YJ; Yang S; Haritunians T; Melmed GY; Vasiliauskas EA; Bonthala N; Syal G; Yarur AJ; Ziring D; Rabizadeh S; Fleshner P; Kallman C; Devkota S; Targan SR; Li D; McGovern DP
    World J Gastrointest Surg; 2024 Mar; 16(3):740-750. PubMed ID: 38577075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
    Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
    EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
    Gu P; Chhabra A; Chittajallu P; Chang C; Mendez D; Gilman A; Fudman DI; Xi Y; Feagins LA
    Inflamm Bowel Dis; 2022 May; 28(5):657-666. PubMed ID: 34291800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
    Gu P; Dube S; Lee Y; Yang S; Li D; Haritunians T; Vasiliauskas E; Bonthala N; Syal G; Yarur A; Ziring D; Targan S; Rabizadeh S; Melmed GY; Fleshner P; McGovern DPB
    Dig Dis Sci; 2024 Jan; 69(1):235-245. PubMed ID: 38015321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
    Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal adipose tissue radiodensity is associated with survival after colorectal cancer.
    Feliciano EMC; Winkels RM; Meyerhardt JA; Prado CM; Afman LA; Caan BJ
    Am J Clin Nutr; 2021 Dec; 114(6):1917-1924. PubMed ID: 34510172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor metabolic activity is associated with subcutaneous adipose tissue radiodensity and survival in non-small cell lung cancer.
    Sun Y; Deng M; Gevaert O; Aberle M; Olde Damink SW; van Dijk D; Rensen SS
    Clin Nutr; 2024 May; 43(7):1809-1815. PubMed ID: 38870661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
    Zulian A; Cancello R; Micheletto G; Gentilini D; Gilardini L; Danelli P; Invitti C
    Gut; 2012 Jan; 61(1):86-94. PubMed ID: 21930728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body Composition Predictors of Complicated Crohn's Disease.
    Barajas Ordonez F; Melekh B; Rodríguez-Feria P; Melekh O; Thormann M; Damm R; Omari J; Pech M; Surov A
    Dig Dis; 2023; 41(4):589-599. PubMed ID: 36720207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
    Fukushima T; Maetani T; Chubachi S; Tanabe N; Asakura T; Namkoong H; Tanaka H; Shimada T; Azekawa S; Otake S; Nakagawara K; Watase M; Shiraishi Y; Terai H; Sasaki M; Ueda S; Kato Y; Harada N; Suzuki S; Yoshida S; Tateno H; Yamada Y; Jinzaki M; Hirai T; Okada Y; Koike R; Ishii M; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
    Metabolism; 2024 Jan; 150():155715. PubMed ID: 37918794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in abdominal, but not femoral subcutaneous fat CT-radiodensity is associated with improved metabolic profile after bariatric surgery.
    Dadson P; Rebelos E; Honka H; Juárez-Orozco LE; Kalliokoski KK; Iozzo P; Teuho J; Salminen P; Pihlajamäki J; Hannukainen JC; Nuutila P
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2363-2371. PubMed ID: 32919861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adiposity predicts post-operative Crohn's disease recurrence.
    Holt DQ; Moore GT; Strauss BJ; Hamilton AL; De Cruz P; Kamm MA
    Aliment Pharmacol Ther; 2017 May; 45(9):1255-1264. PubMed ID: 28244124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Visceral Adipose Tissue to Subcutaneous Adipose Tissue Ratio as a Predictor of Mortality in Acute Respiratory Distress Syndrome.
    Ni YN; Yu H; Xu H; Li WJ; Liang BM; Yang L; Liang ZA
    Am J Med Sci; 2019 Mar; 357(3):213-222. PubMed ID: 30797502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer.
    Cheng E; Caan BJ; Chen WY; Irwin ML; Prado CM; Cespedes Feliciano EM
    Clin Nutr; 2022 Dec; 41(12):2607-2613. PubMed ID: 36306565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy.
    Ebadi M; Moctezuma-Velazquez C; Meza-Junco J; Baracos VE; DunichandHoedl AR; Ghosh S; Sarlieve P; Owen RJ; Kneteman N; Montano-Loza AJ
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein.
    Faber DR; Moll FL; Vink A; van der Waal C; Kalkhoven E; Schipper HS; Hajer GR; Monajemi H; Visseren FL
    Int J Obes (Lond); 2012 Aug; 36(8):1078-85. PubMed ID: 22064157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
    Rivière P; Vermeire S; Irles-Depe M; Van Assche G; Rutgeerts P; Denost Q; Wolthuis A; D'Hoore A; Laharie D; Ferrante M
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):713-720.e1. PubMed ID: 32272248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
    Van Der Sloot KW; Joshi AD; Bellavance DR; Gilpin KK; Stewart KO; Lochhead P; Garber JJ; Giallourakis C; Yajnik V; Ananthakrishnan AN; Alizadeh BZ; Xavier RJ; Khalili H
    Inflamm Bowel Dis; 2017 Jan; 23(1):82-88. PubMed ID: 27893544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study.
    Gu L; Zhang Y; Hong J; Xu B; Yang L; Yan K; Zhang J; Chen P; Zheng J; Lin J
    Front Oncol; 2021; 11():680190. PubMed ID: 34249721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.